Eva Munck af Rosenschöld Wikland is a Professor affiliated with the Department of Clinical Science, Intervention and Technology at Karolinska Institutet, specializing in the Division of Oto-Rhino-Laryngology. Her work bridges clinical research and oncology, with a focus on head and neck cancers. Research Interests: Her research spans HPV-related oropharyngeal cancers, tumor immunology, molecular biomarkers, and surgical outcomes. She investigates prognostic factors such as HPV status, p16 expression, immune cell infiltration, and genetic markers in tonsillar and base of tongue cancers. Her work also addresses complications like osteoradionecrosis and reconstructive surgery outcomes. The recent publications (2020–2023) highlight her focus on immune responses in tumor-draining lymph nodes, sentinel node analysis, FGF11 as a prognostic marker in HPV-positive cancers, and the role of brachytherapy and microvascular reconstruction in managing complications. These works reflect interdisciplinary collaboration across immunology, virology, and surgical oncology. Scientific Awards: No specific awards listed in the provided text. Advising and Grants: While no formal list of students or grants is provided, her extensive co-authorship on multicenter studies and clinical trials suggests active mentorship and involvement in funded research projects. She has contributed to prospective randomized trials and large epidemiological studies on HPV and cancer outcomes. Labs and Teams: She collaborates closely with research groups at Karolinska Institutet focused on virology (Dalianis group), tumor immunology, and head and neck oncology. Her work is integral to studies on HPV diagnostics, cancer of unknown primary, and biomarker validation.








